2023-04-01 2024-03-31 false Capium Accounts Production 1.1 10694219 2023-04-01 2024-03-31 10694219 bus:AbridgedAccounts 2023-04-01 2024-03-31 10694219 bus:FRS102 2023-04-01 2024-03-31 10694219 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 10694219 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 10694219 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10694219 2023-04-01 2024-03-31 10694219 2024-03-31 10694219 bus:RegisteredOffice 2023-04-01 2024-03-31 10694219 core:WithinOneYear 2024-03-31 10694219 core:AfterOneYear 2024-03-31 10694219 1 2023-04-01 2024-03-31 10694219 bus:Director1 2023-04-01 2024-03-31 10694219 bus:Director1 2024-03-31 10694219 bus:Director1 2022-04-01 2023-03-31 10694219 2022-04-01 10694219 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 10694219 2022-04-01 2023-03-31 10694219 2023-03-31 10694219 core:WithinOneYear 2023-03-31 10694219 core:AfterOneYear 2023-03-31 10694219 bus:EntityAccountantsOrAuditors 2022-04-01 2023-03-31 10694219 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 10694219 bus:OrdinaryShareClass1 2024-03-31 10694219 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 10694219 bus:OrdinaryShareClass1 2023-03-31 10694219 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 10694219 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 10694219 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-03-31 10694219 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 10694219 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 10694219 core:Non-currentFinancialInstruments 2024-03-31 10694219 core:Non-currentFinancialInstruments 2023-03-31 10694219 core:ShareCapital 2024-03-31 10694219 core:ShareCapital 2023-03-31 10694219 core:RetainedEarningsAccumulatedLosses 2024-03-31 10694219 core:RetainedEarningsAccumulatedLosses 2023-03-31 10694219 dpl:Item1 2023-04-01 10694219 dpl:Item1 2024-03-31 10694219 dpl:Item1 2022-04-01 10694219 dpl:Item1 2023-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10694219
England and Wales

 

 

 

UH MEDICS LTD


Abridged Accounts
 


Period of accounts

Start date: 01 April 2023

End date: 31 March 2024
Accountant’s report
You consider that the company is exempt from an audit for the year ended 31 March 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
TAXACC SERVICES LTD
31 March 2024



....................................................
TAXACC SERVICES LTD
438 Streatham High Road
Streatham
London
SW16 3PX
08 January 2025
1
 
 
Notes
 
2024
£
  2023
£
Current assets      
Debtors: amounts falling due after one year 158,020    158,020 
Cash at bank and in hand 55,313    122,244 
213,333    280,264 
Creditors: amount falling due within one year (81,025)   (162,072)
Net current assets 132,308    118,192 
 
Total assets less current liabilities 132,308    118,192 
Net assets 132,308    118,192 
 

Capital and reserves
     
Called up share capital 4 100    100 
Profit and loss account 132,208    118,092 
Shareholders' funds 132,308    118,192 
 


For the year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 08 January 2025 and were signed by:


-------------------------------
Muhammad Haroon Razzaq
Director
2
General Information
UH Medics Ltd is a private company, limited by shares, registered in England and Wales, registration number 10694219, registration address 438 Streatham High Road, London, SW16 3PX.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2.

Staff Costs

2024
£
  2023
£
Wages and salaries 16,272    9,810 
Social security costs 161    91 
Pension costs, defined contribution plan 5,500   
Other staff costs 1,209    304 
23,142    10,205 
 
Average number of employees during the year Number   Number
Administration 1    1 
 

3.

Average number of employees

Average number of employees during the year was 2 (2023 : 1).
4.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
100 Class A shares of £1.00 each 100    100 
100    100 

3